Stay updated on ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Sign up to get notified when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.

Latest updates to the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 with no visible changes to study details or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page shows a minor software version update from v3.4.0 to v3.4.1 with no visible changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThis update consists of minor UI/text changes: a Show glossary option was added, and the footer now includes 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0. Legacy texts such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedPage shows a new revision tag (Revision: v3.3.4) replacing the previous tag (Revision: v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocation sections were updated to reflect added study sites in California, Florida, Pennsylvania, Texas, New South Wales, Queensland, Victoria, and Western Australia, with older site lists removed. The page revision is updated to v3.3.3 (replacing v3.3.2).SummaryDifference1.0%

- Check91 days agoChange DetectedThe Publications section now notes that items are auto-filled from PubMed and may not pertain to the study, and the revision label in the page footer changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.